4D Molecular Therapeutics, Inc. (FDMT) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 701.60M USD. 52-week range 6.96 to 16.93 USD. Data as of 2026-10-09.
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related ...